NCT00460499View on ClinicalTrials.gov

Improving Outcomes In Diabetic Patients During CABG Surgery By Optimizing Glycemic Control

PHASE1CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Glycemic Control
Interventions
DRUG

A IV Insulin drip

These patients will receive 100units of insulin in 100ml of saline intravenously to keep blood glucose between 120-180mg/dl.

DRUG

B Low Dose GIK

These patients will receive D5W+80unitsInsulin+40mEqKCL IV to keep blood glucose between 120-180mg/dl

DRUG

C High Dose GIK

This group will receive D20W+160units IV insulin to keep blood sugar between 120-180mg/dl

Trial Locations (1)

02118

Boston Medical Center, Boston

All Listed Sponsors
lead

American Heart Association

OTHER

NCT00460499 - Improving Outcomes In Diabetic Patients During CABG Surgery By Optimizing Glycemic Control | Biotech Hunter | Biotech Hunter